GGrantIndex
Sort

51,593 grants matching hepatitis

Role of Innate and Adaptive Immune Systems in Drug-Induced Liver Disease

$1,266,331
Lance R Pohl · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL

International epidemiologic Database to Evaluate AIDS (West Africa) Core

$1,266,160
Francois Dabis · University Of Bordeaux Ii · U01 · FY2008 · AI

The Asia-Pacific HIV Observational Database (APHOD)

$1,265,804
David A Cooper · Foundation For Aids Research · U01 · FY2009 · AI

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$1,265,745
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Collaborative Integration of HCV Molecular Virology and Mathematical Modeling

$1,265,369
Susan L Uprichard · Loyola University Chicago · R01 · FY2025 · AI

LICI Microbiome and Genetics Core

$1,264,977
Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

Mid Southern Primary Care Networks Node

$1,264,138
Li-Tzy T Wu · Duke University · UG1 · FY2017 · DA

Conduct Synthesis and Acquire Batches of Compounds for Subsequent Biological In Vitro and In Vivo Testing

$1,264,071
Mark Middleton · Starks Associates, Inc. · N01 · FY2024 · AI

Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP

$1,263,633
Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Center for Interventional Oncology

$1,263,405
Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2025 · CA

Novel Ondansetron Formulation for Combination Treatment of Psychostimulant Abuse

$1,263,356
Tong H Lee · Duke University · RC2 · FY2010 · DA

Integrated Epithelial and Mucosal Biology

$1,261,366
Wayne Lencer · Boston Children'S Hospital · P30 · FY2018 · DK

Development of a human physiological multi-cellular liver platform for drug-induced liver injury and disease.

$1,261,020
Brian Robert Wamhoff · Hemoshear Therapeutics, Llc · R44 · FY2015 · DK

Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Markets and Drug Tourism

$1,260,610
Steffanie A Strathdee · University Of California, San Diego · R01 · FY2022 · DA

Molecular Genetics Of Heritable Human Disorders

$1,260,469
Janice Chou · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD

Non-Human Primate Core (NHP Core)

$1,260,301
Koen K Van Rompay · Duke University · P01 · FY2016 · AI

Task A10: Efficacy Testing of Therapeutics for Hepatitis C

$1,260,145
Norman Kneteman · Kmt Hepatech, Inc. · N01 · FY2011 · AI

Multicenter AIDS Cohort Study

$1,260,025
Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI

Fructokinase Inhibitors for the Treatment of Alcohol Use Disorder

$1,259,901
Richard Joseph Johnson · Colorado Research Partners, Llc · U01 · FY2020 · AA

Genetic and Cellular Mechanisms of NAFLD and Hepatic Insulin Resistance

$1,259,742
Gerald I Shulman · Yale University · R24 · FY2010 · DK

TIM recognition of phosphatidylserine regulates innate and adaptive immunity

$1,258,635
Dale T Umetsu · Boston Children'S Hospital · P01 · FY2011 · AI

Clinical Pharmacogenetics

$1,257,271
William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

CTSA INFRASTRUCTURE FOR AIDS RESEARCH

$1,256,490
Barry Coller · Rockefeller University · UL1 · FY2007 · RR

Yale Liver Center

$1,256,253
Michael H Nathanson · Yale University · P30 · FY2025 · DK

Yale Liver Center

$1,256,253
Michael H Nathanson · Yale University · P30 · FY2024 · DK